News

Viking's leading drug candidate could be a blockbuster in the weight loss market, which experts believe could grow to $150 billion over the coming years.
Utilizing a filamentous fungus in the gut microbiome may provide a new strategy for treating metabolic dysfunction-associated ...
The man who helped inspire menus at Carlos O’Kelly’s and Red Beans To-Go, Rick Jeffrey, has been in a desperate search for a ...
The researchers then investigated how the metabolisms of treated mice changed. They found that the effect was caused by ...
Choline is a nutrient that is very important for our health, but many people don’t think much about it. Our bodies make a ...
Researchers say semaglutide, the medication in Ozempic and Wegovy, may help reverse MASH, a progressive liver condition ...
A late-stage clinical study showed that this weight loss drug helped 2 out of 3 people with the life-threatening liver ...
There is no standard of care for fibrolamellar liver cancer, no targeted therapies. But that may be changing, thanks to recent findings by rare cancer researcher Dr. Taran Gujral, head of Fred Hutch's ...
The Italian study showed that patients with HCC resulting from viral infections or fatty liver had significantly higher ...
Four South Florida clinics are enrolling patients in a nationwide trial for a vitamin that may offer a solution for slowing memory loss and halting the progression of Alzheimer’s disease. The trial ...